Literature DB >> 8537211

Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.

Y Miyamoto1, T Tsujimoto, K Iwai, K Ishida, R Uchimoto, T Miyazawa, H Azuma.   

Abstract

RATIONALE AND
OBJECTIVES: The authors compared the safety and pharmacokinetics of Iotrolan (water-soluble) in hysterosalpingography (HSG) with those of Lipiodol (oil-soluble).
METHODS: Iotrolan and Lipiodol were administered intraperitoneally at doses of 100 mg iodine/kg to female rabbits. Retention in the body was investigated by x-ray imaging, plasma kinetics, and urinary and fecal excretion. Irritability in the abdomen was investigated by histologic examination.
RESULTS: Iotrolan was entirely excreted into the urine within 2 days after administration. Conversely, Lipiodol was excreted into the urine, had a half-life of 50 days, and was retained for more than 21 days in the abdomen. Iotrolan induced no inflammatory reaction in the abdomen, whereas Lipiodol induced a marked abdominal inflammatory reaction, including granuloma formation. Iotrolan had no effect on iodine concentration in the thyroid; Lipiodol increased iodine concentration significantly.
CONCLUSIONS: Iotrolan, which is a water-soluble and nonionic dimeric contrast medium, has potential greater safety for use in HSG than Lipiodol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537211     DOI: 10.1097/00004424-199509000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  The Impact of Preconceptional Hysterosalpingography with Oil-based Contrast on Maternal and Neonatal Iodine Status.

Authors:  Rongrong Li; Wei Chen; Yanping Liu; Liangkun Ma; Ling Qiu; Jianhua Han; Rui Li
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 3.060

2.  Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast.

Authors:  N van Welie; I Roest; M Portela; J van Rijswijk; C Koks; C B Lambalk; K Dreyer; B W J Mol; M J J Finken; V Mijatovic
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

3.  Hysterosalpingography with Oil-Soluble Contrast Medium Does Not Increase Newborn Hypothyroidism.

Authors:  Divya M Mathews; Jane M Peart; Neil P Johnson; Robert G Sim; Natasha L Heather; Dianne Webster; Susannah O'Sullivan; Paul L Hofman
Journal:  Int J Endocrinol       Date:  2022-02-22       Impact factor: 3.257

4.  Effects of oil-soluble versus water-soluble contrast media at hysterosalpingography on pregnancy outcomes in women with a low risk of tubal disease: study protocol for a randomised controlled trial.

Authors:  Guiling Liang; Qian Zhu; Xiaoqing He; Xiaofeng Wang; Ling Jiang; Chenfeng Zhu; Li Xie; Zhaoxia Qian; Jian Zhang
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.